HBMN — HBM Healthcare Investments AG Share News
0.000.00%
- CH₣1.48bn
- CH₣1.63bn
- CH₣297.06m
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics
Media: DKSH said to bid for Swiss drug distributor Swixx Biopharma - Bloomberg News
Swiss stocks - Factors to watch on July 18
Brief: HBM Healthcare Investments Says Qtrly NAV Per Share Declined By 8.4 Percent
Swiss stocks - Factors to watch on July 2
Brief: HBM Considers $1.7 Billion Sale Of Swixx Biopharma- Bloomberg News
Swiss stocks - Factors to watch on January 20
Brief: HBM Healthcare Investments Reports Profit Of CHF 66 Mln In First Nine Months
Swiss stocks - Factors to watch on October 21
Brief: HBM Healthcare Investments Says HY Profit Of CHF 23 Mln
Brief: HBM Healthcare Says Qtrly Profit Of CHF 26 Mln
Brief: HBM Healthcare Investments AG Says Co Signs Agreement To Acquire Laboratorios Biopas Group
Brief: HBM Healthcare Says Co Will Use Portion Of Available Cash To Implement Current Share Buyback Programme
Brief: HBM Healthcare Says Reports A Loss Of CHF 59 mln For Q2 2023/2024 Financial Year As of September 30
Swiss stocks - Factors to watch on October 16
Brief: HBM Healthcare Investments Says Closed Q1 Of 2023/2024 Financial Year As At 30 June 2023 With A Loss Of CHF 11 Million
Swiss stocks - Factors to watch on June 26